These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3786368)

  • 1. Simultaneous brightness discrimination and reversal: the effects of amphetamine administration in the two stages.
    Weiner I; Feldon J; Ben-Shahar O
    Pharmacol Biochem Behav; 1986 Nov; 25(5):939-42. PubMed ID: 3786368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal and nonreversal shifts under amphetamine.
    Weiner I; Feldon J
    Psychopharmacology (Berl); 1986; 89(3):355-9. PubMed ID: 3088663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine and the overtraining reversal effect.
    Weiner I; Ben Horin E; Feldon J
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1539-42. PubMed ID: 3737622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation of discrimination transfers under amphetamine: the relative control by S+ and S- and general transfer effects.
    Weiner I; Feldon J; Ben-Horin E
    Psychopharmacology (Berl); 1987; 93(2):261-7. PubMed ID: 3122260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adolescent exposure to methylmercury and d-amphetamine on reversal learning and an extradimensional shift in male mice.
    Boomhower SR; Newland MC
    Exp Clin Psychopharmacol; 2017 Apr; 25(2):64-73. PubMed ID: 28287789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. d-Amphetamine effects on attention and memory in the albino and hooded rat.
    Beckwith BE; Sandman CA; Alexander WD; Gerald MC; Goldman H
    Pharmacol Biochem Behav; 1974; 2(4):557-61. PubMed ID: 4423372
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of GM1 ganglioside, AGF2, and D-amphetamine as treatments for spatial reversal and place learning deficits following lesions of the neostriatum.
    Dunbar GL; Lescaudron LL; Stein DG
    Behav Brain Res; 1993 Mar; 54(1):67-79. PubMed ID: 8504013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of overtraining and pretrial administration of dextroamphetamine on reversal learning in rats.
    Mead PG
    Percept Mot Skills; 1974 Apr; 38(2):566. PubMed ID: 4824094
    [No Abstract]   [Full Text] [Related]  

  • 9. d-Amphetamine: disruptive effects on the long-term store of memory and proactive facilitatory effects on learning in inbred mice.
    Crabbe JC; Alpern HP
    Pharmacol Biochem Behav; 1975; 3(4):647-52. PubMed ID: 1187728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perseverative behaviour after amphetamine; dissociation of response tendency from reward association.
    Ridley RM; Baker HF; Haystead TA
    Psychopharmacology (Berl); 1981; 75(3):283-6. PubMed ID: 6798619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral protein synthesis inhibition and discrimination training: effects of D-amphetamine.
    Squire LR
    Brain Res; 1979 Nov; 177(2):401-6. PubMed ID: 497841
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of prior experience on differential learning under amphetamine.
    Grilly DM
    Psychopharmacologia; 1975 Sep; 43(3):271-7. PubMed ID: 1187959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d-Amphetamine discrimination established under a conditional discrimination procedure in pigeons.
    Watanabe S
    Yakubutsu Seishin Kodo; 1983 May; 3(1):45-50. PubMed ID: 6666378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of trimethyltin on acquisition and reversal of a light-dark discrimination by rats.
    Woodruff ML; Baisden RH; Cannon RL; Kalbfleisch J; Freeman JN
    Physiol Behav; 1994 Jun; 55(6):1055-61. PubMed ID: 8047571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of pimozide to disrupt the acquisition of light-dark and spatial discrimination problems.
    Tombaugh TN; Szostak C; Mills P
    Psychopharmacology (Berl); 1983; 79(2-3):161-8. PubMed ID: 6405423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of some discriminative properties of d-amphetamine.
    Kuhn DM; Appel JB; Greenberg I
    Psychopharmacologia; 1974; 39(1):57-66. PubMed ID: 4138622
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effects of 2,5-dimethoxy-4-iodoamphetamine and D-amphetamine on the ability of rats to discriminate the durations and intensities of light stimuli.
    Hampson CL; Body S; den Boon FS; Cheung TH; Bezzina G; Langley RW; Fone KC; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2010 Feb; 21(1):11-20. PubMed ID: 19949322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitating effects of pre- and posttrial amphetamine administration on discrimination learning in mice.
    Krivanek JA; McGaugh JL
    Agents Actions; 1969 Nov; 1(2):36-42. PubMed ID: 5406195
    [No Abstract]   [Full Text] [Related]  

  • 19. Twenty-four-hour proactive facilitation of avoidance and discrimination learning in rats by d-amphetamine.
    Bauer RH; Duncan NC
    J Comp Physiol Psychol; 1971 Dec; 77(3):521-7. PubMed ID: 5118261
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasopressin and vasotocin facilitate reversal of a brightness discrimination.
    Beckwith BE; Tinius TP
    Peptides; 1985; 6(3):383-6. PubMed ID: 4070013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.